science
Study Suggests Ozempic and Wegovy May Slow Biological Aging in Adults
14 Temmuz 2026Science Daily
- Researchers have discovered that semaglutide, the active ingredient in popular weight-loss drugs Ozempic and Wegovy, may slow biological aging markers in adults with HIV. This marks the first clinical evidence suggesting that the drug could influence human aging.
- However, experts caution that larger studies are necessary to confirm these findings before making definitive claims about the drug's effects on aging.
- The exploration of medications that can influence aging is a burgeoning field of research, particularly as the global population ages. Semaglutide's potential effects on biological aging could provide a new perspective on how weight management strategies can also contribute to longevity and overall health.
- The implications of this research are significant, as it opens up new avenues for understanding the relationship between weight-loss medications and biological aging. If further studies validate these findings, semaglutide could not only be a tool for weight management but also play a role in promoting healthier agi…
NewsAI özeti
This article is based on preliminary research findings and should not be considered as medical advice. Further studies are needed to validate these results.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.